SCHEMBL29133737

SCHEMBL29133737

CCC1(Nc2c(C#N)cnc3ccc(-c4cncc(C#N)c4)cc23)C=CC=CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.42
▸ IRAK4 Q9NWZ3 2/20 0.40
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ EGFR P00533 7/20 0.37
▸ PRKDC P78527 4/20 0.37
▸ PIK3CA P42336 2/20 0.37
▸ PIK3CG P48736 1/20 0.36
▸ SRC P12931 3/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ FLT1 P17948 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ SYK P43405 1/20 0.36
▸ GSK3B P49841 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ MELK Q14680 3/20 0.34
▸ PRMT5 O14744 1/20 0.33
▸ WDR77 Q9BQA1 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133763 0.90 MELK (0.38) IRAK4EGFRPRKDCPIK3CASRC
SCHEMBL29133706 0.88 ATM (0.40) EGFRPRKDCPIK3CASRCABL1
SCHEMBL29133701 0.88 PIK3CA (0.38) IRAK4CYP11B1CYP11B2EGFRPRKDC
SCHEMBL29133758 0.86 EGFR (0.42) MAP4K4EGFRPRKDCPIK3CAPIK3CG
SCHEMBL29133729 0.86 EGFR (0.52) IRAK4EGFRPRKDCPIK3CASRC
SCHEMBL29133713 0.85 EGFR (0.44) EGFRPRKDCPIK3CAPIK3CGSRC
SCHEMBL29133769 0.84 PIK3CA (0.46) PIK3CAPIK3CG
SCHEMBL29133705 0.84 EGFR (0.41) EGFRPRKDCPIK3CASRCABL1
SCHEMBL29133697 0.83 MELK (0.49) EGFRPRKDCMELK
SCHEMBL29133779 0.82 EGFR (0.41) EGFRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback